About The Study: This cohort study describes respiratory syncytial virus (RSV)-associated lower respiratory tract infection hospitalizations among infants in France who received both maternal RSVpreF vaccination and nirsevimab during the 2024-2025 RSV season.
Corresponding Author: To contact the corresponding author, Ludovic Tréluyer, MD, PhD, email ludovic.treluyer@ansm.sante.fr.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2026.1346)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2026.1346?guestAccessKey=e2814820-b22a-4ec5-9158-da67534c2541&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051826
Journal
JAMA Pediatrics